Clustering data with hclust algorithm for Metabolite changes associated with methionine stress sensitivity of cancer (CSH QTOF MS analysis) (Study ST000077)
ESI/QTOF positive ion mode (Analysis AN000123)Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 |
---|---|---|---|---|---|---|---|---|---|
LPC (16:0) | ME655693 | 0.32 | 0.22 | 0.21 | 0.28 | 0.28 | 0.22 | 0.24 | 7.72 |
PC (36:4) | ME655715 | 0.33 | 0.50 | 0.49 | 0.40 | 0.76 | 0.47 | 0.53 | 5.55 |
TG (52:4) | ME655800 | 0.42 | 0.43 | 0.31 | 0.27 | 0.40 | 0.37 | 0.50 | 6.54 |
LPC (18:0) | ME655694 | 0.75 | 0.58 | 0.50 | 0.88 | 0.62 | 0.68 | 0.67 | 3.98 |
TG (54:5) | ME655809 | 0.59 | 0.81 | 0.65 | 0.42 | 1.16 | 0.63 | 0.92 | 3.41 |
PC (38:6) | ME655724 | 0.81 | 0.77 | 0.71 | 0.62 | 1.26 | 0.71 | 0.86 | 2.62 |
TG (52:5) | ME655801 | 0.78 | 0.89 | 0.65 | 0.58 | 1.17 | 0.80 | 1.08 | 2.43 |
LPC (18:1) | ME655695 | 0.78 | 0.90 | 0.55 | 0.84 | 0.86 | 0.73 | 0.80 | 3.00 |
TG (54:6) | ME655810 | 0.76 | 0.81 | 0.57 | 0.60 | 1.07 | 0.78 | 1.00 | 2.89 |
TG (50:4) | ME655792 | 0.89 | 0.86 | 0.59 | 0.55 | 0.89 | 0.76 | 1.02 | 2.94 |
TG (54:4) | ME655808 | 0.90 | 0.94 | 0.66 | 0.55 | 0.87 | 0.75 | 1.03 | 2.76 |
Dioctyl phthalate | ME655688 | 0.90 | 0.93 | 0.90 | 0.77 | 1.00 | 0.81 | 0.91 | 2.01 |
TG (52:3) | ME655799 | 1.05 | 0.90 | 0.58 | 0.75 | 0.78 | 0.91 | 1.03 | 2.34 |
PC (40:8) | ME655732 | 0.90 | 0.48 | 0.15 | 2.35 | 0.16 | 2.19 | 1.30 | 0.39 |
PC (42:10) | ME655733 | 0.81 | 0.47 | 0.13 | 2.43 | 0.20 | 2.28 | 1.34 | 0.22 |
PC-O (36:3) (plasmanyl/plasmenyl) | ME655740 | 0.70 | 1.88 | 0.95 | 0.68 | 0.85 | 0.65 | 2.20 | 0.20 |
CE (16:1) | ME655676 | 1.17 | 1.19 | 1.23 | 0.74 | 0.81 | 0.79 | 1.03 | 1.08 |
CE (18:1) | ME655677 | 1.09 | 1.28 | 1.49 | 0.66 | 0.72 | 0.68 | 0.95 | 1.15 |
PC (36:5) | ME655716 | 1.31 | 0.71 | 0.38 | 1.29 | 0.67 | 1.17 | 1.10 | 1.51 |
DG (36:3) | ME655685 | 1.10 | 0.82 | 0.64 | 1.14 | 1.02 | 0.97 | 1.00 | 1.43 |
Cholesterol | ME655682 | 0.87 | 0.98 | 1.02 | 0.94 | 0.97 | 0.95 | 0.93 | 1.42 |
PC (36:5) C | ME655717 | 0.91 | 0.97 | 0.90 | 1.00 | 0.87 | 0.96 | 0.91 | 1.61 |
TG (56:8) | ME655820 | 1.22 | 0.99 | 0.47 | 0.88 | 0.71 | 1.21 | 1.50 | 1.21 |
TG (50:3) | ME655791 | 1.36 | 0.91 | 0.52 | 0.87 | 0.79 | 1.03 | 1.16 | 1.54 |
TG (51:3) | ME655795 | 1.17 | 1.01 | 0.67 | 0.78 | 0.90 | 1.01 | 1.26 | 1.34 |
PC (40:5) A | ME655729 | 1.26 | 0.91 | 0.57 | 0.95 | 0.97 | 1.06 | 1.18 | 1.20 |
TG (48:3) | ME655784 | 1.44 | 0.93 | 0.56 | 0.86 | 0.87 | 1.03 | 1.18 | 1.23 |
SM (d18:1/16:1) | ME655771 | 1.34 | 1.02 | 0.85 | 0.87 | 0.93 | 0.87 | 1.03 | 1.13 |
PC (34:2) | ME655708 | 1.23 | 0.98 | 0.74 | 1.10 | 0.69 | 1.04 | 1.04 | 1.24 |
PC (38:3) | ME655722 | 1.23 | 1.05 | 0.80 | 0.94 | 0.65 | 0.96 | 1.08 | 1.42 |
PC (40:6) A | ME655730 | 1.76 | 1.00 | 0.52 | 1.19 | 0.53 | 1.31 | 1.38 | 0.21 |
PC (33:2) | ME655707 | 1.85 | 1.01 | 0.59 | 1.21 | 0.64 | 1.13 | 1.17 | 0.25 |
N-(15Z-tetracosenoyl)-1-.beta.-galactosyl-sphing-4-enine | ME655696 | 1.76 | 1.16 | 0.74 | 1.20 | 0.56 | 1.14 | 1.26 | 0.02 |
PC (42:6) | ME655735 | 1.65 | 1.06 | 0.65 | 1.20 | 0.70 | 1.21 | 1.24 | 0.13 |
PC (32:2) | ME655704 | 1.99 | 0.88 | 0.46 | 1.48 | 0.56 | 1.25 | 1.10 | 0.06 |
PC (38:7) | ME655726 | 1.59 | 0.90 | 0.45 | 1.49 | 0.67 | 1.32 | 1.24 | 0.19 |
PC (40:1) | ME655727 | 1.66 | 0.99 | 0.55 | 1.52 | 0.47 | 1.36 | 1.26 | 0.02 |
PC (38:5) A | ME655723 | 1.28 | 1.02 | 0.58 | 1.16 | 0.76 | 1.28 | 1.33 | 0.56 |
PC (40:7) | ME655731 | 1.31 | 1.12 | 0.62 | 1.25 | 0.63 | 1.38 | 1.41 | 0.18 |
PC (34:3) | ME655709 | 1.59 | 1.02 | 0.75 | 1.09 | 0.78 | 1.06 | 1.18 | 0.43 |
PC (35:3) | ME655711 | 1.36 | 1.24 | 0.95 | 0.97 | 0.78 | 1.05 | 1.22 | 0.32 |
SM (d18:1/14:0) | ME655770 | 1.47 | 1.15 | 0.91 | 1.03 | 0.78 | 1.01 | 1.15 | 0.37 |
PS (36:2) | ME655766 | 1.37 | 1.24 | 0.69 | 1.14 | 0.74 | 1.17 | 1.25 | 0.30 |
TG 66:3;TG(22:1/22:1/22:1) | ME655833 | 1.40 | 1.12 | 0.82 | 1.13 | 0.78 | 1.23 | 1.15 | 0.20 |
PC (32:0) | ME655702 | 1.13 | 1.12 | 0.91 | 1.24 | 0.91 | 1.26 | 1.19 | 0.06 |
PC (40:3) | ME655728 | 1.54 | 1.17 | 0.82 | 1.14 | 0.66 | 1.14 | 1.29 | 0.08 |
PC-O (34:0) (plasmanyl/plasmenyl) | ME655737 | 1.34 | 1.24 | 0.97 | 1.12 | 0.74 | 1.13 | 1.27 | 0.01 |
PC (38:2) | ME655721 | 1.43 | 1.18 | 0.92 | 1.20 | 0.68 | 1.16 | 1.20 | 0.03 |
PC-O (32:0) (plasmanyl/plasmenyl) | ME655736 | 1.33 | 1.19 | 0.94 | 1.25 | 0.62 | 1.24 | 1.24 | 0.02 |
PC (30:1) | ME655701 | 1.74 | 0.88 | 0.64 | 1.37 | 0.92 | 1.17 | 1.04 | 0.01 |
DG (36:2) | ME655684 | 1.38 | 0.98 | 0.65 | 1.51 | 0.81 | 1.25 | 1.19 | 0.05 |
DG (34:1) | ME655683 | 1.33 | 0.99 | 0.74 | 1.31 | 0.99 | 1.17 | 1.22 | 0.06 |
DG (38:5) | ME655686 | 1.45 | 1.10 | 0.65 | 1.30 | 0.81 | 1.12 | 1.30 | 0.13 |
Ceramide (d40:1) | ME655679 | 0.79 | 1.51 | 1.53 | 0.43 | 1.54 | 0.68 | 1.28 | 0.06 |
PC-O (40:7) (plasmanyl/plasmenyl) A | ME655747 | 1.14 | 1.46 | 1.57 | 0.61 | 1.06 | 0.72 | 1.17 | 0.09 |
Ceramide (d18:1/23:0) | ME655678 | 0.98 | 1.46 | 1.24 | 0.59 | 1.20 | 0.86 | 1.32 | 0.26 |
PS (38:3) | ME655767 | 0.91 | 1.28 | 1.47 | 0.74 | 1.36 | 0.86 | 1.11 | 0.07 |
PC-O (38:6) (plasmanyl/plasmenyl) | ME655745 | 1.03 | 1.35 | 1.35 | 0.71 | 1.22 | 0.84 | 1.21 | 0.12 |
PC-O (40:5) (plasmanyl/plasmenyl) | ME655746 | 1.07 | 1.24 | 1.34 | 0.74 | 1.31 | 0.81 | 1.11 | 0.23 |
TG (50:1) | ME655789 | 0.87 | 1.16 | 1.43 | 0.60 | 1.63 | 0.71 | 0.98 | 0.49 |
plasmenyl-PE 36:1 | ME655760 | 1.13 | 1.02 | 1.26 | 0.81 | 1.77 | 0.80 | 0.94 | 0.02 |
plasmenyl-PE 38:3 | ME655764 | 1.03 | 0.96 | 1.17 | 0.86 | 1.85 | 0.83 | 0.93 | 0.11 |
PE-O (38:5) (plasmanyl/plasmenyl) | ME655753 | 1.06 | 0.96 | 1.23 | 0.75 | 1.94 | 0.76 | 0.93 | 0.15 |
PE-O (40:6) (plasmanyl/plasmenyl) | ME655755 | 1.07 | 1.01 | 1.22 | 0.75 | 1.84 | 0.78 | 1.00 | 0.10 |
Ceramide (d42:1) | ME655680 | 1.14 | 1.19 | 1.26 | 0.60 | 1.66 | 0.74 | 1.08 | 0.14 |
GlcCer (40:1) | ME655689 | 1.16 | 1.21 | 1.32 | 0.61 | 1.81 | 0.61 | 1.01 | 0.05 |
TG (46:1) | ME655779 | 1.02 | 1.12 | 1.20 | 0.57 | 1.96 | 0.73 | 1.06 | 0.13 |
TG (48:1) | ME655782 | 0.92 | 1.19 | 1.37 | 0.56 | 1.77 | 0.72 | 1.06 | 0.21 |
TG (56:2) | ME655814 | 0.93 | 1.19 | 1.35 | 0.61 | 1.82 | 0.78 | 1.05 | 0.04 |
PC (36:6) A | ME655718 | 1.24 | 0.89 | 0.83 | 0.91 | 1.71 | 0.91 | 1.06 | 0.29 |
plasmenyl-PE 40:4 | ME655765 | 1.25 | 0.99 | 0.93 | 0.80 | 1.64 | 1.03 | 1.00 | 0.15 |
SM (d40:1) | ME655772 | 1.06 | 0.97 | 1.06 | 0.85 | 1.59 | 0.83 | 0.95 | 0.57 |
SM (d42:1) | ME655774 | 1.05 | 0.98 | 1.05 | 0.87 | 1.75 | 0.85 | 0.95 | 0.33 |
DG 38:4;DG(18:0/20:4/0:0) | ME655687 | 1.37 | 1.07 | 0.93 | 0.95 | 1.40 | 0.87 | 1.18 | 0.03 |
PC (33:1) | ME655706 | 1.29 | 1.07 | 1.00 | 0.96 | 1.39 | 0.96 | 1.07 | 0.02 |
TG (60:2) | ME655827 | 1.32 | 1.05 | 1.05 | 0.93 | 1.36 | 0.99 | 1.01 | 0.06 |
GlcCer (42:1) | ME655690 | 1.29 | 1.12 | 1.03 | 0.82 | 1.61 | 0.80 | 1.07 | 0.04 |
PC (36:1) | ME655712 | 1.10 | 1.08 | 1.08 | 0.95 | 1.42 | 0.97 | 1.07 | 0.12 |
TG (58:2) | ME655821 | 1.18 | 1.12 | 1.15 | 0.78 | 1.54 | 0.90 | 1.08 | 0.04 |
PE-O (36:5) (plasmanyl/plasmenyl) | ME655752 | 1.20 | 1.07 | 1.23 | 0.82 | 1.51 | 0.86 | 1.03 | 0.04 |
PE-O (38:6) (plasmanyl/plasmenyl) | ME655754 | 1.19 | 1.08 | 1.30 | 0.84 | 1.44 | 0.85 | 1.05 | 0.03 |
1-Stearoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine | ME655673 | 1.17 | 1.07 | 1.26 | 0.93 | 1.39 | 0.91 | 1.02 | 0.02 |
plasmenyl-PE 34:1 | ME655758 | 1.14 | 1.07 | 1.24 | 0.91 | 1.49 | 0.90 | 1.00 | 0.01 |
plasmenyl-PE 36:2 | ME655761 | 1.08 | 1.05 | 1.24 | 0.94 | 1.27 | 0.91 | 0.96 | 0.39 |
plasmenyl-PE 38:1 | ME655762 | 1.20 | 1.15 | 1.21 | 0.88 | 1.23 | 0.89 | 1.03 | 0.21 |
plasmenyl-PE 38:2 | ME655763 | 1.28 | 1.14 | 1.34 | 0.88 | 1.16 | 0.87 | 1.07 | 0.03 |
TG (56:5) | ME655817 | 0.88 | 1.20 | 1.03 | 0.56 | 1.70 | 0.83 | 1.24 | 0.49 |
TG (51:2) | ME655794 | 1.04 | 1.27 | 1.06 | 0.59 | 1.56 | 0.83 | 1.29 | 0.25 |
TG (58:5) | ME655824 | 0.96 | 1.31 | 0.94 | 0.61 | 1.68 | 0.89 | 1.36 | 0.12 |
TG (58:6) | ME655825 | 0.92 | 1.20 | 0.98 | 0.69 | 1.75 | 0.92 | 1.27 | 0.11 |
TG (53:2) | ME655803 | 1.00 | 1.19 | 1.15 | 0.67 | 1.61 | 0.84 | 1.11 | 0.28 |
TG (54:2) | ME655806 | 1.01 | 1.19 | 1.21 | 0.75 | 1.48 | 0.92 | 1.11 | 0.15 |
TG (55:3) | ME655812 | 1.16 | 1.31 | 0.99 | 0.69 | 1.39 | 0.95 | 1.33 | 0.02 |
TG (49:2) | ME655787 | 1.14 | 1.21 | 0.92 | 0.68 | 1.41 | 0.93 | 1.29 | 0.32 |
TG (60:5) | ME655828 | 1.05 | 1.30 | 1.09 | 0.69 | 1.43 | 0.91 | 1.26 | 0.13 |
TG (56:4) | ME655816 | 1.05 | 1.20 | 0.97 | 0.77 | 1.42 | 0.99 | 1.24 | 0.24 |
TG (58:4) A | ME655823 | 1.09 | 1.24 | 1.03 | 0.76 | 1.38 | 0.96 | 1.24 | 0.15 |
PC (28:0) | ME655699 | 1.43 | 0.90 | 0.90 | 1.15 | 1.39 | 1.01 | 0.96 | 0.00 |
Benzyl dodecyl dimethylammonium cation | ME655674 | 1.46 | 0.94 | 0.73 | 1.15 | 1.32 | 0.99 | 1.17 | 0.04 |
Benzyl tetradecyl dimethylammonium cation | ME655675 | 1.47 | 0.85 | 0.58 | 1.29 | 1.44 | 1.00 | 1.08 | 0.08 |
TG 58:7;TG(18:0/18:2/22:5) | ME655830 | 1.32 | 1.28 | 0.70 | 0.76 | 1.04 | 1.13 | 1.55 | 0.15 |
TG (58:8) | ME655826 | 1.34 | 1.23 | 0.64 | 0.84 | 0.85 | 1.26 | 1.62 | 0.16 |
PC (42:5) | ME655734 | 1.32 | 0.92 | 0.96 | 1.04 | 1.19 | 1.03 | 1.10 | 0.28 |
PC (18:1/16:0) | ME655698 | 1.10 | 1.08 | 1.06 | 1.06 | 1.13 | 1.05 | 1.07 | 0.29 |
PS (38:4) | ME655768 | 1.07 | 1.20 | 0.95 | 0.92 | 1.14 | 1.04 | 1.23 | 0.34 |
N-Tetracosenoyl-4-sphingenyl-1-O-phosphorylcholine | ME655697 | 1.25 | 1.11 | 1.05 | 1.03 | 1.08 | 1.00 | 1.11 | 0.22 |
plasmenyl-PE 34:2 | ME655759 | 1.33 | 1.12 | 1.13 | 1.05 | 1.03 | 0.98 | 1.06 | 0.10 |
PC-O (36:2) (plasmanyl/plasmenyl) | ME655739 | 1.22 | 1.15 | 1.24 | 1.02 | 1.08 | 0.98 | 1.07 | 0.02 |
PC-O (38:5) (plasmanyl/plasmenyl) B | ME655744 | 1.14 | 1.12 | 1.23 | 1.02 | 1.11 | 0.99 | 1.04 | 0.16 |
plasmenyl-PC 36:3 | ME655757 | 1.14 | 1.25 | 1.13 | 1.01 | 1.12 | 1.02 | 1.08 | 0.02 |
SM (d44:2) | ME655775 | 1.25 | 1.16 | 1.09 | 0.98 | 1.17 | 0.97 | 1.12 | 0.06 |
plasmenyl-PC 34:0 | ME655756 | 1.18 | 1.05 | 1.08 | 1.06 | 1.22 | 1.09 | 1.07 | 0.03 |
1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | ME655671 | 1.20 | 1.15 | 1.13 | 1.09 | 1.00 | 1.08 | 1.10 | 0.03 |
1-hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine | ME655672 | 1.20 | 1.18 | 1.11 | 1.10 | 0.94 | 1.10 | 1.15 | 0.01 |
PC (32:3) | ME655705 | 1.15 | 1.13 | 1.02 | 1.17 | 1.05 | 1.13 | 1.12 | 0.01 |
PC (30:0) | ME655700 | 1.25 | 1.10 | 0.99 | 1.14 | 1.04 | 1.12 | 1.13 | 0.01 |
PC (32:1) | ME655703 | 1.21 | 1.09 | 1.00 | 1.14 | 1.10 | 1.11 | 1.11 | 0.03 |
TG (56:3) | ME655815 | 1.30 | 1.24 | 0.88 | 0.99 | 0.91 | 1.18 | 1.29 | 0.04 |
Lactosylceramide (d18:1/24:1(15Z)) | ME655692 | 1.61 | 1.06 | 0.87 | 1.05 | 0.99 | 0.98 | 1.16 | 0.07 |
PC (37:2) | ME655719 | 1.36 | 1.11 | 0.96 | 1.09 | 1.05 | 1.06 | 1.12 | 0.05 |
TG 60:3;TG(20:1/20:1/20:1) | ME655831 | 1.40 | 1.16 | 0.92 | 0.94 | 1.04 | 1.09 | 1.20 | 0.07 |
PC (35:2) | ME655710 | 1.46 | 1.12 | 0.91 | 1.08 | 0.92 | 1.06 | 1.14 | 0.14 |
PC-O (34:2) (plasmanyl/plasmenyl) A | ME655738 | 1.33 | 1.14 | 1.04 | 1.09 | 0.91 | 1.04 | 1.09 | 0.17 |
PC (37:3) | ME655720 | 1.40 | 1.08 | 1.16 | 0.90 | 0.96 | 0.93 | 1.12 | 0.31 |
PC-O (42:5) (plasmanyl/plasmenyl) | ME655750 | 1.31 | 1.26 | 1.13 | 0.78 | 0.98 | 0.83 | 1.21 | 0.39 |
PC-O (44:5) (plasmanyl/plasmenyl) | ME655751 | 1.27 | 1.32 | 1.12 | 0.80 | 0.80 | 0.88 | 1.27 | 0.47 |
Ceramide (d42:2) | ME655681 | 1.10 | 1.39 | 1.05 | 0.81 | 0.96 | 1.10 | 1.44 | 0.02 |
PC-O (40:7) (plasmanyl/plasmenyl) B | ME655748 | 1.18 | 1.26 | 1.17 | 0.81 | 1.06 | 0.95 | 1.24 | 0.18 |
PC-O (36:4) (plasmanyl/plasmenyl) | ME655741 | 1.03 | 1.32 | 1.19 | 0.83 | 1.07 | 0.91 | 1.24 | 0.28 |
PC-O (38:5) (plasmanyl/plasmenyl) A | ME655743 | 1.13 | 1.34 | 1.27 | 0.80 | 0.98 | 0.90 | 1.22 | 0.23 |
PC-O (40:8) (plasmanyl/plasmenyl) | ME655749 | 1.03 | 1.34 | 1.31 | 0.86 | 1.01 | 0.95 | 1.19 | 0.14 |
GlcCer (42:2) | ME655691 | 1.42 | 1.30 | 1.10 | 0.81 | 1.10 | 0.82 | 1.23 | 0.04 |
TG (58:3) | ME655822 | 1.23 | 1.27 | 1.03 | 0.81 | 1.17 | 1.01 | 1.24 | 0.07 |
TG (52:2) | ME655798 | 1.06 | 1.09 | 0.98 | 0.88 | 1.16 | 0.99 | 1.09 | 0.70 |
PC-O (36:5) (plasmanyl/plasmenyl) | ME655742 | 1.18 | 1.17 | 0.85 | 0.85 | 1.10 | 0.97 | 1.26 | 0.57 |
TG (50:2) | ME655790 | 1.14 | 1.14 | 0.95 | 0.79 | 1.24 | 0.97 | 1.18 | 0.53 |
PC (36:3) A | ME655714 | 1.37 | 1.15 | 0.87 | 0.97 | 0.68 | 1.02 | 1.18 | 0.74 |
TG (54:3) | ME655807 | 1.20 | 1.08 | 0.80 | 1.07 | 0.91 | 1.19 | 1.19 | 0.49 |
PC (38:6) B | ME655725 | 1.17 | 1.18 | 0.98 | 1.03 | 0.75 | 1.07 | 1.15 | 0.62 |
SM (34:1) | ME655769 | 1.24 | 1.07 | 0.96 | 0.97 | 1.02 | 0.95 | 1.09 | 0.65 |
SM (d40:2) A | ME655773 | 1.23 | 1.07 | 0.96 | 1.01 | 0.92 | 0.97 | 1.07 | 0.72 |
PC (36:2) | ME655713 | 1.13 | 1.08 | 1.00 | 1.07 | 0.91 | 1.06 | 1.07 | 0.60 |
TG 62:3;TG(18:1/22:1/22:1) | ME655832 | 1.25 | 1.06 | 0.93 | 1.05 | 0.91 | 1.10 | 1.07 | 0.53 |
TG (56:7) | ME655819 | 0.92 | 1.14 | 0.73 | 0.66 | 1.33 | 0.98 | 1.39 | 0.92 |
TG 54:7;TG(16:0/18:2/20:5) | ME655829 | 1.07 | 1.11 | 0.68 | 0.75 | 1.33 | 1.04 | 1.44 | 0.59 |
TG (56:6) | ME655818 | 1.02 | 1.16 | 0.74 | 0.74 | 1.22 | 1.08 | 1.43 | 0.63 |
TG (53:3) | ME655804 | 1.24 | 1.25 | 0.82 | 0.74 | 1.16 | 1.03 | 1.39 | 0.30 |
TG (46:2) | ME655780 | 1.41 | 0.99 | 0.71 | 0.78 | 1.40 | 0.99 | 1.19 | 0.46 |
TG (48:2) | ME655783 | 1.31 | 1.10 | 0.80 | 0.81 | 1.31 | 1.00 | 1.22 | 0.34 |
TG (52:0) | ME655796 | 0.22 | 0.67 | 2.11 | 0.12 | 3.87 | 0.16 | 0.34 | 0.13 |
TG (44:1) | ME655777 | 1.00 | 0.99 | 1.10 | 0.53 | 2.31 | 0.69 | 0.98 | 0.19 |
TG (50:0) | ME655788 | 0.39 | 1.02 | 2.23 | 0.19 | 2.82 | 0.27 | 0.58 | 0.18 |
TG (54:1) | ME655805 | 0.48 | 0.96 | 1.79 | 0.27 | 3.08 | 0.37 | 0.64 | 0.10 |
TG (49:1) | ME655786 | 0.77 | 1.26 | 1.45 | 0.42 | 2.04 | 0.59 | 1.07 | 0.21 |
TG (52:1) | ME655797 | 0.68 | 1.16 | 1.69 | 0.42 | 2.18 | 0.55 | 0.87 | 0.21 |
TG (46:0) | ME655778 | 0.62 | 1.12 | 1.93 | 0.29 | 2.43 | 0.40 | 0.78 | 0.17 |
TG (48:0) | ME655781 | 0.58 | 1.10 | 2.09 | 0.31 | 2.23 | 0.39 | 0.75 | 0.31 |
TG (14:0/14:0/14:0) | ME655776 | 0.71 | 0.94 | 1.43 | 0.44 | 2.60 | 0.54 | 0.77 | 0.35 |
TG (51:1) | ME655793 | 0.61 | 1.24 | 1.62 | 0.31 | 2.47 | 0.47 | 0.94 | 0.11 |
TG (55:1) | ME655811 | 0.65 | 1.05 | 1.61 | 0.42 | 2.59 | 0.52 | 0.77 | 0.12 |
TG (56:1) | ME655813 | 0.74 | 0.97 | 1.65 | 0.42 | 2.63 | 0.49 | 0.74 | 0.06 |
TG (49:0) | ME655785 | 0.51 | 1.13 | 1.85 | 0.29 | 2.64 | 0.40 | 0.76 | 0.16 |
TG (53:1) | ME655802 | 0.56 | 1.11 | 1.67 | 0.34 | 2.65 | 0.46 | 0.82 | 0.12 |
Factors:
F1 | Treatment:100uM Met | Timepoint:0 hours |
F2 | Treatment:370uM Hcy | Timepoint:12 hours |
F3 | Treatment:370uM Hcy | Timepoint:24 hours |
F4 | Treatment:370uM Hcy | Timepoint:2 hours |
F5 | Treatment:370uM Hcy | Timepoint:48 hours |
F6 | Treatment:370uM Hcy | Timepoint:4 hours |
F7 | Treatment:370uM Hcy | Timepoint:8 hours |
F8 | Treatment:quality check | Timepoint:quality check |